About Predxbio
Predxbio is a Healthcare company based in Pittsburgh (United States) founded in 2017 by Chakra Chennubhotla. It operates as an AI-based drug discovery and clinical services are provided for biopharma. Predxbio has raised $2 million across 8 funding rounds from investors including National Science Foundation and Newlin Investment Company. Predxbio offers products and services including Spatially Intelligent Platform, SpaceIQ Platform, and Whitepaper Solutions. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Image Analysis. Its legal entity is PredxBio, Inc. Its competitors include PathAI, Viz.ai, Deepcell, Deciphex and Pictor Labs and 2 more; 7 of its 7 listed competitors have raised funding.
Company details
Predxbio was founded in 2017 and is headquartered in Pittsburgh, United States. AI technologies are utilized by the company to support drug discovery and clinical development processes within the biopharma sector. Services are offered to biopharmaceutical firms seeking to accelerate research and development timelines through data-driven approaches. Operations focus on integrating artificial intelligence into therapeutic innovation pipelines.
- Headquarters Pittsburgh, United States
- Founders Chakra Chennubhotla
- SectorsHealthcare
- Website predxbio.com
- Social LinkedIn X
- Legal Name Predxbio, Inc.
- Total Equity Funding$2M (USD)
in 8 rounds
- Latest Funding Round$601.32K (USD), Series B
Aug 2023
- InvestorsNational Science Foundation
& 1 more
Products & Services of Predxbio
Predxbio offers a comprehensive portfolio of products and services, including Spatially Intelligent Platform, SpaceIQ Platform, and Whitepaper Solutions.
Platform for identifying biomarkers in cancer immunotherapy using AI.
Tool for spatial data analysis in drug discovery and clinical trials.
Resource providing insights on spatial biology for immunotherapy advancements.
Funding Insights of Predxbio
Predxbio has successfully raised a total of $2M across 8 strategic funding rounds. The most recent funding activity was a Series B round of $601.32 thousand completed in August 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $2M
- Total Rounds 8
- Last Round Series B — $601,321
- Investors Count 2
All 8 funding rounds of Predxbio with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2023 | $601,321 | Series B | – | – | – |
| Feb 2021 | $260,000 | Seed | – | – | – |
| Aug 2020 | $463,257 | Seed | – | – | – |
| Aug 2019 | $225,000 | Grant | – | – | |
| Aug 2019 | $275,000 | Seed | – | – | – |
| Feb 2019 | $224,999 | Grant | – | – | |
| Sep 2018 | $400,000 | Seed | – | Newlin Investment | – |
| Sep 2018 | – | Debt – Conventional | – | – |
2 investors in total: 2 institutional.
Investors in Predxbio
Predxbio has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include National Science Foundation and Newlin Investment Company.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
A private equity and venture capital investor is operated. | – | newlininvestment.com | Sewickley, United States | |
A government-backed foundation providing seed-stage investments to support small businesses. | 1950 | nsf.gov | Arlington, United States |
Investor details for Predxbio
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Predxbio
1 people are tracked at Predxbio (1 in leadership).
| Name | Role | Group |
|---|---|---|
Chakra Chennubhotla | Co-Founder & President | Leadership |
Complete people profiles for Predxbio
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Predxbio
3 dated milestones of Predxbio across 6 years, from founding to its latest funding, stage changes and deals.
- Founded Predxbio is founded.
- Funding First funding round.
- Funding Latest funding round, Series B, of $601K.
Competitors of Predxbio
Predxbio has 7 listed competitors in our database, 7 of them funded. They include PathAI, Viz.ai, Deepcell, Deciphex and Pictor Labs, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| pathai.com | 2016 | Boston, United States | $254.94M | 573 | Provider of AI-based solutions for clinical diagnosis of cancer and other diseases | |
| viz.ai | 2016 | San Francisco, United States | $251.99M | 206 | AI and cloud-powered software for stroke care coordination is developed. | |
| deepcell.com | 2015 | Mountain View, United States | $122.99M | 94 | AI-powered single cell classification and isolation technology for clinical research | |
| deciphex.com | 2017 | Dublin, Ireland | $56.65M | – | Digital pathology software is developed for clinical and veterinary productivity. | |
| pictorlabs.ai | 2019 | Los Angeles, United States | $48.83M | – | AI-based tools for pathological image analysis are provided to labs. | |
| paige.ai | 2018 | New York, United States | $241M | – | AI-enabled tools for computational pathology and cancer diagnostics are provided. | |
| enspectrahealth.com | 2014 | Mountain View, United States | $15.55M | 8 | Developer of medical devices for tissue imagining and cancer detection |
Detailed competitors of Predxbio
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Predxbio
The website of Predxbio (predxbio.com) receives about 2.2K visits a month.
- Monthly visits2.2K
▲ 43.2% vs previous month
Websites whose visitors overlap most with Predxbio. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| plexision.com | 100% | 3.2K | #5,846,553 | View details | |
| starrlifesciences.com | 99% | 2.8K | #5,697,666 | View details | |
| bluespherebio.com | 99% | 2.5K | #6,529,430 | View details | |
pittbioforge.org | pittbioforge.org | 98% | – | #6,533,171 | – |
| imaginepharma.com | 98% | – | – | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 12 similar websites and full traffic analytics for Predxbio
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 12 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Clinical IT & Data Platforms
10 companies that operate in the same segment as Predxbio (Clinical IT & Data Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Provider of fitness memberships encompassing group classes, gyms, and at-home workouts | 2016 | Bengaluru, Karnataka, India | USD 713.57 M | – | – | |
Employee health benefits are facilitated via a cloud-based platform. | 2007 | Plymouth Meeting, Pennsylvania, United States | USD 228.3 M | – | – | |
Healthcare appointments are booked online via Zocdoc's platform. | 2007 | New York, New York, United States | USD 425.97 M | USD 4.66 M | 233 | |
Virtual physical therapy and digital pain care solutions are provided. | 2015 | San Francisco, California, United States | USD 854.44 M | – | – | |
Tech-enabled mental health solutions for employers are provided. | 2016 | New York, New York, United States | USD 508.73 M | – | – | |
App-based health insurance is offered to individuals and businesses. | 2016 | Paris, France | USD 863.12 M | – | – | |
Virtual care programs for managing chronic diseases are provided. | 2011 | San Francisco, California, United States | USD 450.12 M | USD 260.21 M | – | |
AI-driven EMR and practice management software is delivered for clinics. | 2010 | Boca Raton, Florida, United States | USD 329.17 M | – | – | |
Cloud-based administrative tools for healthcare providers are offered. | 1997 | Watertown, United States | USD 40 M | – | – | |
Membership-based primary care platform is offered for employees and consumers. | 2007 | San Francisco, California, United States | USD 402.56 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Predxbio
Complete news archive for Predxbio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Predxbio
Predxbio was founded in 2017 and raised its 1st funding round 1 year after it was founded.
Predxbio is headquartered in Pittsburgh, United States. It is registered at Pittsburgh, Pennsylvania, United States.
Predxbio is a funded company, having raised a total of $2M across 8 funding rounds to date.
Predxbio was founded in 2017 and is headquartered in Pittsburgh, United States. AI technologies are utilized by the company to support drug discovery and clinical development processes within the biopharma sector. Services are offered to biopharmaceutical firms seeking to accelerate research and development timelines through data-driven approaches. Operations focus on integrating artificial intelligence into therapeutic innovation pipelines.
Predxbio's top competitors include Deciphex, Pictor Labs and PathAI.
Predxbio offers Spatially Intelligent Platform, SpaceIQ Platform, and Whitepaper Solutions.
Predxbio has 2 investors. Key investors include National Science Foundation, and Newlin Investment Company.
Predxbio operates through Predxbio, Inc..